Modelling human channelopathies using induced pluripotent stem cells: A comprehensive review

Stem Cells International

Volumn , Issue , 2013, Pages

  Müller, Martin ^a   Seufferlein, Thomas ^a   Illing, Anett ^a   Homann, Jörg ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.2; FLECAINIDE; MEXILETINE; NIFEDIPINE; PINACIDIL; POTASSIUM CHANNEL KCNQ1; RANOLAZINE; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; VERAPAMIL;

DISEASE MODEL; GENE MUTATION; HEART ARRHYTHMIA; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HUMAN; LONG QT SYNDROME; LONG QT SYNDROME 1; LONG QT SYNDROME 2; LONG QT SYNDROME 3; NONHUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TIMOTHY SYNDROME;

IPS;

EID: 84878735985     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/496501     Document Type: Review

References (42)

1. Schwartz P. J., Stramba-Badiale M., Crotti L., Pedrazzini M., Besana A., Bosi G., Gabbarini F., Goulene K., Insolia R., Mannarino S., Mosca F., Nespoli L., Rimini A., Rosati E., Salice P., Spazzolini C., Prevalence of the congenital long-QT syndrome. Circulation 2009 120 18 1761 1767 2-s2.0-70449367296 10.1161/CIRCULATIONAHA.109.863209
2. Martin C. A., Matthews G. D., Huang C. L., Sudden cardiac death and inherited channelopathy: the basic electrophysiology of the myocyte and myocardium in ion channel disease. Heart 2012 98 7 536 543
3. Grant A. O., Cardiac ion channels. Circulation 2009 2 2 185 194
4. Morita H., Wu J., Zipes D. P., The QT syndromes: long and short. The Lancet 2008 372 9640 750 763 2-s2.0-50149112857 10.1016/S0140-6736(08)61307-0
5. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 131 5 861 872 2-s2.0-36248966518 10.1016/j.cell.2007.11.019 (Pubitemid 350138099)
6. Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007 318 5858 1917 1920 2-s2.0-36749043230 10.1126/science. 1151526
7. Liebau S., Mahaddalkar P. U., Kestler H. A., Illing A., Seufferlein T., Kleger A., A hierarchy in reprogramming capacity in different tissue microenvironments: what we know and what we need to know. Stem Cells and Development 2013 22 5 695 706 10.1089/scd. 2012.0461
8. Linta L., Stockmann M., Boeckers T. M., Kleger A., Liebau S., The potential of iPS cells in synucleinopathy research. Stem Cells and Development 2012 2012 6 629230
9. Kleger A., Mahaddalkar P. U., Katz S. F., Lechel A., Joo J. Y., Loya K., Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. Gastroenterology 2012 142 4 907 917
10. Maehr R., Chen S., Snitow M., Ludwig T., Yagasaki L., Goland R., Leibel R. L., Melton D. A., Generation of pluripotent stem cells from patients with type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America 2009 106 37 15768 15773 2-s2.0-70349437501 10.1073/pnas.0906894106
11. Raya A., Rodríguez-Piz I., Guenechea G., Vassena R., Navarro S., Barrero M. J., Consiglio A., Castell M., Río P., Sleep E., González F., Tiscornia G., Garreta E., Aasen T., Veiga A., Verma I. M., Surrallés J., Bueren J., Belmonte J. C. I., Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009 460 7251 53 59 2-s2.0-67650095306 10.1038/nature08129
12. Rashid S. T., Corbineau S., Hannan N., Marciniak S. J., Miranda E., Alexander G., Huang-Doran I., Griffin J., Ahrlund-Richter L., Skepper J., Semple R., Weber A., Lomas D. A., Vallier L., Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. Journal of Clinical Investigation 2010 120 9 3127 3136 2-s2.0-77956354416 10.1172/JCI43122
13. Liu G. H., Barkho B. Z., Ruiz S., Diep D., Qu J., Yang S. L., Panopoulos A. D., Suzuki K., Kurian L., Walsh C., Thompson J., Boue S., Fung H. L., Sancho-Martinez I., Zhang K., Iii J. Y., Belmonte J. C. I., Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011 472 7342 221 227 2-s2.0-79954626173 10.1038/nature09879
14. Brennand K. J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011 473 221 225
15. Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011 471 7337 225 229
16. Ge X., Ren Y., Bartulos O., Lee M. Y., Yue Z., Kim K. Y., Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation 2012 126 14 1695 1704
17. Davis R. P., Casini S., van den Berg C. W., Hoekstra M., Remme C. A., Dambrot C., Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 2012 125 25 3079 3091
18. Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O. J., Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Science Translational Medicine 2012 4 130 130ra47
19. Jung C. B., Moretti A., Mederos y Schnitzler M., Iop L., Storch U., Bellin M., Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Molecular Medicine 2012 4 3 180 191
20. Yazawa M., Hsueh B., Jia X., Pasca A. M., Bernstein J. A., Hallmayer J., Dolmetsch R. E., Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011 471 7337 230 236 2-s2.0-79952438377 10.1038/nature09855
21. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L. S., Nguemo F., Menke S., Haustein M., Hescheler J., Hasenfuss G., Martin U., Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008 118 5 507 517 2-s2.0-49649096192 10.1161/CIRCULATIONAHA. 108.778795
22. Carvajal-Vergara X., Sevilla A., Dsouza S. L., Ang Y. S., Schaniel C., Lee D. F., Yang L., Kaplan A. D., Adler E. D., Rozov R., Ge Y., Cohen N., Edelmann L. J., Chang B., Waghray A., Su J., Pardo S., Lichtenbelt K. D., Tartaglia M., Gelb B. D., Lemischka I. R., Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010 465 7299 808 812 2-s2.0-77953443251 10.1038/nature09005
23. Donger C., Denjoy I., Berthet M., Neyroud N., Cruaud C., Bennaceur M., Chivoret G., Schwartz K., Coumel P., Guicheney P., KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997 96 9 2778 2781 2-s2.0-19244371485 (Pubitemid 27500069)
24. Shimizu W., Antzelevitch C., Differential effects of beta-adrenergic agonists and antagonist in LQT1, LQT2 and LQT3 models of the long QT syndrome. Journal of the American College of Cardiology 2000 35 3 778 786 2-s2.0-0034163543 10.1016/S0735-1097(99)00582-3 (Pubitemid 30167037)
25. Moretti A., Bellin M., Welling A., Jung C. B., Lam J. T., Bott-Flugel L., Patient-specific induced pluripotent stem-cell models for long-QT syndrome. The New England Journal of Medicine 2010 363 15 1397 1409
26. Matsa E., Rajamohan D., Dick E., Young L., Mellor I., Staniforth A., Denning C., Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. European Heart Journal 2011 32 8 952 962 2-s2.0-79954523845 10.1093/eurheartj/ehr073
27. Lahti A. L., Kujala V. J., Chapman H., Koivisto A. P., Pekkanen-Mattila M., Kerkela E., Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Disease Models and Mechanisms 2012 5 2 220 230
28. Malan D., Friedrichs S., Fleischmann B. K., Sasse P., Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circulation Research 2011 109 8 841 847
29. Curran M. E., Splawski I., Timothy K. W., Vincent G. M., Green E. D., Keating M. T., A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995 80 5 795 803 2-s2.0-0028914969 10.1016/0092-8674(95) 90358-5
30. Priori S. G., Napolitano C., Schwartz P. J., Grillo M., Bloise R., Ronchetti E., Moncalvo C., Tulipani C., Veia A., Bottelli G., Nastoli J., Association of long QT syndrome loci and cardiac events among patients treated with β -blockers. Journal of the American Medical Association 2004 292 11 1341 1344 2-s2.0-4544387969 10.1001/jama.292.11.1341 (Pubitemid 39223225)
31. Schwartz P. J., Priori S. G., Spazzolini C., Moss A. J., Michael Vincent G., Napolitano C., Denjoy I., Guicheney P., Breithardt G., Keating M. T., Towbin J. A., Beggs A. H., Brink P., Wilde A. A. M., Toivonen L., Zareba W., Robinson J. L., Timothy K. W., Corfield V., Wattanasirichaigoon D., Corbett C., Haverkamp W., Schulze-Bahr E., Lehmann M. H., Schwartz K., Coumel P., Bloise R., Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001 103 1 89 95 2-s2.0-0035830365 (Pubitemid 32050441)
32. Noda T., Shimizu W., Satomi K., Suyama K., Kurita T., Aihara N., Kamakura S., Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome. European Heart Journal 2004 25 23 2149 2154 2-s2.0-9644264340 10.1016/j.ehj.2004.08.020 (Pubitemid 39572248)
33. Noda T., Takaki H., Kurita T., Suyama K., Nagaya N., Taguchi A., Aihara N., Kamakura S., Sunagawa K., Nakamura K., Ohe T., Horie M., Napolitano C., Towbin J. A., Priori S. G., Shimizu W., Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. European Heart Journal 2002 23 12 975 983 2-s2.0-0036623671 10.1053/euhj.2001.3079 (Pubitemid 35203877)
34. Johnson J. N., Tester D. J., Perry J., Salisbury B. A., Reed C. R., Ackerman M. J., Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm 2008 5 5 704 709 2-s2.0-42649145054 10.1016/j.hrthm.2008.02.007
35. Hofman N., Wilde A. A. M., Kääb S., van Langen I. M., Tanck M. W. T., Mannens M. M. A. M., Hinterseer M., Beckmann B. M., Tan H. L., Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? European Heart Journal 2007 28 5 575 580 2-s2.0-34548383412 10.1093/eurheartj/ehl355 (Pubitemid 47355496)
36. Zhang L., Benson D. W., Tristani-Firouzi M., Ptacek L. J., Tawil R., Schwartz P. J., George A. L., Horie M., Andelfinger G., Snow G. L., Fu Y. H., Ackerman M. J., Vincent G. M., Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 2005 111 21 2720 2726 2-s2.0-20344388309 10.1161/CIRCULATIONAHA.104.472498 (Pubitemid 40791541)
37. Moss A. J., Zareba W., Hall W. J., Schwartz P. J., Crampton R. S., Benhorin J., Vincent G. M., Locati E. H., Priori S. G., Napolitano C., Medina A., Zhang L., Robinson J. L., Timothy K., Towbin J. A., Andrews M. L., Effectiveness and limitations of β -blocker therapy in congenital long- QT syndrome. Circulation 2000 101 6 616 623 2-s2.0-17044446589 (Pubitemid 30094732)
38. Priori S. G., Napolitano C., Schwartz P. J., Bloise R., Crotti L., Ronchetti E., The elusive link between LQT3 and brugada syndrome: the role of flecainide challenge. Circulation 2000 102 9 945 947 2-s2.0-0034730085 (Pubitemid 30656000)
39. Marks M. L., Whisler S. L., Clericuzio C., Keating M., A new form of long QT syndrome associated with syndactyly. Journal of the American College of Cardiology 1995 25 1 59 64 2-s2.0-0028842251 10.1016/0735-1097(94)00318-K
40. Reichenbach H., Meister E. M., Theile H., The heart-hand syndrome: a new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet. Kinderarztliche Praxis 1992 60 2 54 56 2-s2.0-0026847447
41. Splawski I., Timothy K. W., Sharpe L. M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P. J., Joseph R. M., Condouris K., Tager-Flusberg H., Priori S. G., Sanguinetti M. C., Keating M. T., CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004 119 1 19 31 2-s2.0-5344223383 10.1016/j.cell.2004.09.011 (Pubitemid 39349317)
42. Yazawa M., Dolmetsch R. E., Modeling timothy syndrome with iPS cells. Journal of Cardiovascular Translational Research 2013 6 1 1 9